Tetrahydrogestrinone is commonly shortened to THG and has been linked with The Clear in doping history. It is not a mainstream medicine or a normal supplement; it belongs in the designer anabolic steroid and sport testing cluster.
That history is important because THG was discussed as a compound designed around detection. A substance built for concealment raises health, legal, sport and product identity concerns at the same time.
What is THG?
Tetrahydrogestrinone should be treated as a designer anabolic steroid identity, not a usable performance option. Public sources support its role in doping history, detection research and androgen activity research.
Health concerns should be read through anabolic steroid risks: liver concern, lipid changes, blood pressure strain, hormone suppression, fertility effects, mood symptoms, acne, hair changes and product uncertainty.
Sport participants face added risk because THG history is tied to anti doping detection and prohibited substance enforcement.
A person exposed to a product claimed to be THG should record every product and source detail and seek care for jaundice, dark urine, chest symptoms, fainting, severe mood changes or other warning signs.
THG needs a different path from routine testosterone ester profiles because the public story is tied to detection, alleged doping and The Clear nickname. That history makes concealment and source doubt part of the medical context.
The health response should not stop at sport consequences. Liver symptoms, cardiovascular symptoms, mood changes, fertility concerns and other substance use still need medical attention if exposure may have occurred.
THG symptoms that need care
THG concern is higher with liver symptoms, chest symptoms, severe mood changes, fainting, high blood pressure or sport testing concern.
| Symptom or situation | Care path |
|---|---|
| Chest pain, severe breathlessness, fainting or a blue tinge to lips | Call emergency services now. |
| Sudden weakness, face droop, speech trouble, severe confusion or loss of coordination | Treat this as a possible stroke. |
| Yellow skin or eyes, very dark urine, severe itching, severe abdominal pain or repeated vomiting | Seek urgent medical care. |
| Fever, spreading redness, heat, pus or red streaking after an injection | Seek same day medical assessment. |
| Suicidal thoughts, violent thoughts, psychosis, extreme agitation or feeling out of control | Get emergency or urgent mental health support. |
Why The Clear history changes concern
PubMed detection literature describes THG identification from syringe residue tied to alleged sport doping. Other research examined androgenic and progestin activity.
The history of concealment means product claims are especially unreliable. A seller may use THG naming for mystique, but the contents may still be unknown.
Anabolic androgenic steroid exposure can affect liver markers, cardiovascular markers, hormone signaling, fertility and mood. Those risks do not disappear because the compound is framed as rare or historic.
Sport status should be handled with qualified advice because testing, documentation and disciplinary processes can become separate problems from immediate health symptoms.
Detection research can establish that a compound was identified in a sport doping context. It cannot verify a current product, predict a personal timeline or make evasion claims useful to a patient.
Rare steroid names can attract attention because they sound specialized. The safer interpretation is the opposite: rare naming gives less certainty, so records and care thresholds become more important.
Doping history and care context
THG claims need a doping history read, a health risk read and a product reliability read. A rare name does not make exposure safer or easier to interpret.
| Layer | What it needs to cover |
|---|---|
| Identity | Separate tetrahydrogestrinone from aliases, ester names, brand names, old medical references and seller labels. |
| Form | Check if the claim is about THG, an ester, a tablet, an injection, a cream, a capsule or a research material. |
| Exposure | Track source, route and exposure date, timing, route, other hormones, alcohol, stimulants, medicines, symptoms and source. |
| Care threshold | Chest symptoms, fainting, jaundice, severe mood change, spreading injection redness or high blood pressure readings move the decision toward care. |
This profile belongs beside metribolone and trestolone because research and sport testing records shape the context, while symptoms still need medical care.
THG exposure questions answered
The Clear name
The nickname points to doping history and should raise caution, not curiosity driven use.
Testing concern
A sport issue should be documented with product records and handled through qualified advice.
Unknown product
A rare compound name on a label may be marketing rather than proof of contents.
Health symptoms
Liver, chest, blood pressure or mood symptoms need care even when the main concern is eligibility.
THG exposure clues
For THG, the history should include the exact name used, The Clear reference if present, source, route, dates, any syringe or container photos and sport documents.
Health details still come first when symptoms are present. Record urine color, abdominal pain, itching, chest symptoms, mood changes, blood pressure and other substances.
If testing or eligibility is involved, keep medical and sport records organized. A clinician can address health while a qualified sport adviser addresses rule processes.
THG records should keep health and sport facts separate. A clinician needs symptoms, substances and labs; a qualified sport adviser needs dates, product evidence, notices and chain of custody details if testing is involved.
After suspected THG exposure
After suspected THG exposure, health symptoms and sport consequences can move on different timelines. Medical symptoms should be handled first.
Product names, The Clear wording, residue or container photos and testing paperwork should be saved because THG history centers on detection and identity.
Care choices after THG claims
| Care decision | A useful answer covers |
|---|---|
| Urgency | Which symptoms need emergency care, same day care or a planned appointment. |
| Checks | Blood pressure, blood count, liver markers, kidney markers, lipids, hormones, infection review, ECG or mental health support when the history supports them. |
| Short term changes | Alcohol, stimulants, training load, dieting and sleep while symptoms are being assessed. |
| Follow up | What improvement should look like and which changes should trigger earlier care. |
What sources can prove about THG
Medical sources can name known risk areas and warning signs. For example, PubChem identifies tetrahydrogestrinone as a steroid substance. Compound records do not establish medical use or product legitimacy. They cannot identify the contents of a product bought outside regulated pharmacy channels.
A label, vial name, tablet color or forum claim cannot prove dose, sterility, purity or safety. When the product source is uncertain, symptom based triage and honest disclosure to a clinician become more important, not less.
THG risk modifiers
| Factor | Why it changes concern |
|---|---|
| Doping history | Raises sport and documentation concern. |
| Unknown product | Contents may not match the rare compound claim. |
| Liver symptoms | Jaundice or dark urine needs care. |
| Mood change | Severe agitation or depression needs support. |
| Other substances | Stacking can hide cause and raise harm. |
THG shortcuts to avoid
- Do not treat a rare compound name as a mark of sophistication.
- Do not ignore health symptoms because the main concern is a test result.
- Do not rely on seller claims about detection.
- Do not discuss dosing or timing as a workaround.
What to bring after THG exposure
Bring product photos, source, route, dates, any sport documents, other substances, symptoms, blood pressure readings and lab reports.
A clinician may review liver and kidney markers, lipids, blood count, hormones, fertility, blood pressure, mental health and urgent symptoms.
THG answers
Is tetrahydrogestrinone a supplement?
No. Treat tetrahydrogestrinone as an anabolic steroid identity unless a licensed clinician and pharmacy context proves a regulated medicine.
Can a label prove the substance?
No. A label, seller photo, batch code or forum report cannot prove contents, dose, purity or sterility.
How does this connect to designer doping compounds?
It sits in the same internal risk cluster as designer doping compounds, with extra attention to identity, route, legal status and care timing.
Tetrahydrogestrinone evidence base
The sources support THG identity, detection history and anabolic steroid risk context. They do not support use or evasion claims.
- PubChem identifies tetrahydrogestrinone as a steroid substance.
- Compound records do not establish medical use or product legitimacy.
- A detection paper describes tetrahydrogestrinone, or THG, identified from syringe residue tied to alleged sport doping.
- The paper supports identity and doping history context.
- A study describes THG as a steroid identified in illicit athletic performance use and examines hormonal properties.
- Research activity does not establish a safe human use pathway.
- A recent review describes anabolic androgenic steroid liver injury as a major concern in treatment and misuse settings.
Sources
THG inside the designer doping cluster
THG belongs beside Metribolone and Trestolone because all three require careful research, detection and sport status context.
For the broader compound map, start with the Steroid types hub before reading rare steroid names in isolation.
If health symptoms are present, move from doping history to Steroid side effects and medical assessment.
Exposure records belong in Doctor disclosure, while source quality and citation handling are explained in Sources and methodology.
Where to read next
Reviewed for Anabolicco by Team Anabolicco. Educational information only; it does not replace care from a qualified clinician.